Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-20

Clinical Trial Update: Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam [Phase 2]

View source ↗

Summary

Phase 2 trial assessing ceftolozane-tazobactam for efficacy, safety, and tolerability in indications related to other infectious diseases; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ceftolozane/Tazobactam (ceftolozane/tazobactam)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Other Infectious Diseases | Phase 2 | Status: COMPLETED | Results posted: 2021-07-20